Morton K. Schwartz

8.7k total citations · 1 hit paper
172 papers, 6.6k citations indexed

About

Morton K. Schwartz is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Morton K. Schwartz has authored 172 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 40 papers in Molecular Biology and 32 papers in Cancer Research. Recurrent topics in Morton K. Schwartz's work include Prostate Cancer Treatment and Research (16 papers), Radiopharmaceutical Chemistry and Applications (15 papers) and Biochemical and Molecular Research (11 papers). Morton K. Schwartz is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), Radiopharmaceutical Chemistry and Applications (15 papers) and Biochemical and Molecular Research (11 papers). Morton K. Schwartz collaborates with scholars based in United States, France and Germany. Morton K. Schwartz's co-authors include Oscar Bodansky, Jerome S. Nisselbaum, Paul Peter Rosen, Martin Fleisher, Celia J. Menendez‐Botet, Howard I. Scher, Ann M. Dnistrian, Herbert F. Oettgen, Harold J. Wanebo and William Kevin Kelly and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Morton K. Schwartz

163 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preoperative Carcinoembryonic Antigen Level as a Prognostic Indicator in Colorectal Cancer

1978 397 citations Morton K. Schwartz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Morton K. Schwartz United States	47	2.1k	1.7k	1.6k	1.1k	788	172	6.6k
M R Melamed United States	45	3.4k 1.6×	1.1k 0.6×	3.8k 2.4×	977 0.9×	638 0.8×	129	10.0k
Stimson P. Schantz United States	49	2.3k 1.1×	986 0.6×	3.1k 1.9×	1.5k 1.4×	1.0k 1.3×	162	8.1k
Kathleen M. Egan United States	49	2.8k 1.3×	1.0k 0.6×	1.6k 1.0×	1.1k 1.0×	1.1k 1.4×	159	7.8k
Jan‐Erik Damber Sweden	49	1.7k 0.8×	4.1k 2.4×	2.3k 1.5×	1.3k 1.2×	1.0k 1.3×	261	8.6k
Philip S. Schein United States	48	2.4k 1.1×	1.2k 0.7×	1.5k 1.0×	511 0.5×	268 0.3×	179	6.5k
Edward T. Creagan United States	37	2.6k 1.2×	956 0.6×	1.5k 0.9×	535 0.5×	544 0.7×	154	5.4k
Frank H. Valone United States	37	2.0k 0.9×	1.3k 0.8×	1.8k 1.2×	660 0.6×	235 0.3×	129	6.2k
Jonathan Waxman United Kingdom	47	1.4k 0.6×	1.5k 0.9×	3.3k 2.1×	1.3k 1.2×	679 0.9×	178	6.5k
Henric Blomgren Sweden	41	1.9k 0.9×	1.6k 1.0×	909 0.6×	401 0.4×	398 0.5×	268	7.7k
Charles Huggins United States	35	956 0.5×	2.1k 1.2×	1.9k 1.2×	1.0k 1.0×	1.4k 1.7×	103	6.7k

Countries citing papers authored by Morton K. Schwartz

Since Specialization

Citations

This map shows the geographic impact of Morton K. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morton K. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morton K. Schwartz more than expected).

Fields of papers citing papers by Morton K. Schwartz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morton K. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morton K. Schwartz. The network helps show where Morton K. Schwartz may publish in the future.

Co-authorship network of co-authors of Morton K. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Morton K. Schwartz. A scholar is included among the top collaborators of Morton K. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morton K. Schwartz. Morton K. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fornier, Monica, Andrew D. Seidman, Morton K. Schwartz, et al.. (2005). Serum HER2 extracellular domain in metastatic breast cancer patients treated with weekly trastuzumab and paclitaxel: association with HER2 status by immunohistochemistry and fluorescence in situ hybridization and with response rate. Annals of Oncology. 16(2). 234–239. 98 indexed citations

Szumlinski, Karen K., Kevin D. Lominac, Erik B. Oleson, et al.. (2005). Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia. Genes Brain & Behavior. 4(5). 273–288. 151 indexed citations

Schwartz, Morton K., et al.. (2000). Monitoring Therapy by Serum HER-2/Neu. The International Journal of Biological Markers. 15(4). 324–329. 49 indexed citations

Kato, Ikuko, Ann M. Dnistrian, Morton K. Schwartz, et al.. (2000). Risk of Iron Overload among Middle-aged Women. International Journal for Vitamin and Nutrition Research. 70(3). 119–125. 29 indexed citations

Kato, Ikuko, Ann M. Dnistrian, Morton K. Schwartz, et al.. (1999). Iron intake, body iron stores and colorectal cancer risk in women: a nested case-control study. International Journal of Cancer. 80(5). 693–698. 83 indexed citations

Scher, Howard I., William Kevin Kelly, Madhu Mazumdar, et al.. (1997). Bicalutamide for advanced prostate cancer: the natural versus treated history of disease.. Journal of Clinical Oncology. 15(8). 2928–2938. 181 indexed citations

Auld, Peter A.M., et al.. (1995). L-2-Oxothiazolidine-4-Carboxylate, a Cysteine Precursor, Stimulates Growth and Normalizes Tissue Glutathione Concentrations in Rats Fed a Sulfur Amino Acid-Deficient Diet. Journal of Nutrition. 125(4). 851–856. 29 indexed citations

Kelly, William K., et al.. (1995). Prospective evaluation of hydrocortisone and suramin in patients with androgen-independent prostate cancer.. Journal of Clinical Oncology. 13(9). 2208–2213. 81 indexed citations

Schwartz, Morton K.. (1994). Post-doctoral training of the non-physician doctoral scientist. Clinica Chimica Acta. 232(1-2). 33–37.

10.

Chan, Daniel W., Roy Beveridge, Arvind K. Bhargava, et al.. (1994). Breast Cancer Marker CA549:A Multicenter Study. American Journal of Clinical Pathology. 101(4). 465–470. 10 indexed citations

11.

Schwartz, Morton K.. (1994). Circulating and Tissue Markers in the Longitudinal Management of Breast Cancer Patients. Advances in experimental medicine and biology. 353. 47–53. 4 indexed citations

12.

Dnistrian, Ann M., et al.. (1993). Effect of tamoxifen on serum cholesterol and lipoproteins during chemohormonal therapy. Clinica Chimica Acta. 223(1-2). 43–52. 35 indexed citations

13.

Schwartz, Morton K.. (1992). Enzymes as prognostic markers and therapeutic indicators in patients with cancer. Clinica Chimica Acta. 206(1-2). 77–82. 41 indexed citations

14.

Dnistrian, Ann M., et al.. (1991). Evaluation of CA M26, CA M29, CA 15-3 and CEA as Circulating Tumor Markers in Breast Cancer Patients. Tumor Biology. 12(2). 82–90. 34 indexed citations

15.

Schwartz, Morton K.. (1990). Enzymes used in predicting high risk to colon cancer. Clinical Biochemistry. 23(5). 395–398. 14 indexed citations

16.

Brew, Bruce J., Ravi B. Bhalla, Humilidad F. Gallardo, et al.. (1990). Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection. Annals of Neurology. 28(4). 556–560. 133 indexed citations

17.

Quagliarello, John, et al.. (1981). Serum Relaxin and Human Chorionic Gonadotropin Concentrations in Spontaneous Abortions. Fertility and Sterility. 36(3). 399–401. 13 indexed citations

18.

Garofalo, John, Martin Lesser, Celia J. Menendez‐Botet, et al.. (1980). Serum zinc, copper, and the Cu/Zn ratio in patients with benign and malignant breast lesions. Cancer. 46(12). 2682–2685. 47 indexed citations

19.

Schwartz, Morton K.. (1975). La mirada de Flora. PubMed. 35(11 Pt. 2). 3481–7. 208 indexed citations

20.

Schwartz, Morton K., Oscar Bodansky, & Henry T. Randall. (1956). Metabolism in Surgical Patients. American Journal of Clinical Nutrition. 4(1). 51–60. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact